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Introduction {#sec1}
============

Aging is accompanied by numerous tissue phenotypes. Changes that occur in postmitotic organs are considered hallmarks of aging. A common feature of aged organisms is functional alteration and gradual loss of muscle mass and force. A deficit of muscle innervation due to motor-neuron loss is believed to have a major contribution to age-dependent muscle wasting, also called sarcopenia. This age-acquired deficit in muscles contributes profoundly to reduced quality of life in elderly people and predisposes them to an increased risk of morbidity, disability, and mortality ([@bib46]). The etiology of sarcopenia is multifaceted and involves several intrinsic and extrinsic factors. Despite the clinical, social, and economic relevance of sarcopenia, the precise mechanisms for the age-related loss of muscle mass and function are not yet fully understood. Age-related changes in muscle are complex, with key features including myofiber atrophy, profound weakness that is partially independent of muscle mass loss, myofiber degeneration, accumulation of dysfunctional mitochondria, and increased oxidative stress. Until recently, it was thought that age-associated atrophy and weakness were secondary to motor-neuron loss in the brain or in the spinal cord. However, this hypothesis has been recently challenged. In fact, little neuronal death occurs in most areas of the aging nervous system, and there is no decline of lower motor neurons during aging ([@bib8; @bib33]). Conversely, it is emerging that neuromuscular junctions (NMJs) and their interactions with myofibers are greatly altered during aging, resulting in a loss of muscle innervation ([@bib8; @bib45]). Oxidative stress and decreased release of trophic factors are independent influences on NMJ integrity and contribute to denervation ([@bib19; @bib20; @bib18]). However, to date, it is not known whether myofiber denervation is due to deleterious changes in muscle cells themselves, in neurons, or both.

Two lifestyle adaptations, caloric restriction and exercise ([@bib20; @bib45]), have been consistently demonstrated to extend lifespan and, in parallel, to mitigate age-related alterations of NMJ. Macroautophagy, hereafter named autophagy, is activated by both of these conditions in skeletal muscles and other tissues ([@bib13; @bib14; @bib15; @bib17; @bib41; @bib48]). Autophagy is a highly conserved homeostatic mechanism used for the degradation and recycling of bulk cytoplasm, long-lived proteins, and organelles through the lysosomal machinery ([@bib32]). The autophagy machinery generates double membrane vesicles (autophagosomes) that engulf and sequester target cellular components ([@bib32]). Autophagosomes are then delivered to and fuse with lysosomes to degrade their contents. Therefore, autophagy can be defined as a process of cytosolic renovation. In mammals, the relationship between autophagy inhibition and aging is still largely phenomenological and correlative. Conversely, robust genetic evidence in worms and flies clearly demonstrates this relationship. Deficient expression of ATG1, ATG7, ATG8, BECN1 (Beclin1), and SESTRIN1 (which is also required for basic autophagy) shortens the lifespan of the fruit fly *D. melanogaster* and of the nematode *C. elegans* ([@bib26; @bib41; @bib44]). On the other hand, increased autophagy contributes to longevity, and mutation of essential Atg genes prevents the gain of longevity ([@bib31]). A recent report shows that aging can be controlled by a single tissue; overexpression of FOXO transcription factor or its target EIF4EBP1 in fly skeletal muscle abolishes the age-associated decline in autophagy and increases longevity ([@bib9]). We previously identified FOXO3A as a regulator of autophagy ([@bib27; @bib28; @bib50]), and genetic variations in the human FOXO3A have been linked to longevity in multiple population studies ([@bib21]). The role of autophagy in sarcopenia in mammals is still controversial. Both impaired and excessive autophagy have been associated with aging sarcopenia ([@bib47; @bib48]). However, loss-of-function experiments that support the involvement of autophagy in aging sarcopenia are still lacking. Here, we show that specific inhibition of autophagy in skeletal muscle leads to abnormalities in motor neuron synapses that ultimately lead to denervation whereas accumulation of dysfunctional mitochondria triggers oxidation of contractile elements, causing a decrease in force generation.

Results {#sec2}
=======

Autophagy Declines during Aging {#sec2.1}
-------------------------------

Age-related muscle loss is believed to result from a general decline of protein synthesis or an enhancement of protein breakdown. To study autophagy in aging, we monitored the expression of autophagy markers, such as LC3 (MAP1LC3A) and the critical E1-like enzyme, ATG7, in mice and humans. Aged mice showed a decline of ATG7 protein and, concurrently, of LC3 lipidation when compared to young animals ([Figure 1](#fig1){ref-type="fig"}A). Then we tested whether this decrease of the autophagy system occurs in humans. An important decrease of ATG7 protein and LC3II was found in muscle biopsies of elderly sedentary (sarcopenic) subjects ([Figure 1](#fig1){ref-type="fig"}B). Because exercise activates autophagy and counteracts most age-related characteristics, including the decline of muscle mass ([@bib49]), we tested whether long-life regular exercise in humans was able to prevent the reduction of these autophagy markers. ATG7 protein and LC3II were maintained in muscle biopsies of senior sportsmen that had been previously shown to have better muscle mass and strength than elderly sedentary subjects ([@bib49]).

Autophagy Inhibition Affects Neuromuscular Synaptic Morphology and Function {#sec2.2}
---------------------------------------------------------------------------

To mimic the decrease of ATG7 in aging, we characterized muscle-specific autophagy-deficient (*Atg7*^*−/−*^) mice that we have generated ([@bib30]). The absence of autophagy caused a significant reduction of animal survival ([Figure 2](#fig2){ref-type="fig"}A). Morphological analyses of aged mice showed higher levels of atrophy, center-nucleated fibers, and inflammation in *Atg7*^*−/−*^ muscles compared to age-matched controls ([Figures 2](#fig2){ref-type="fig"}B and [S1](#app2){ref-type="sec"}A). Fiber size was affected in *Atg7*^*−/−*^, and fibers displayed great variability in dimension. Some fibers atrophied to a level that made them hardly detectable ([Figure 2](#fig2){ref-type="fig"}C). These small fibers did not express the typical markers of regeneration and, therefore, are adult atrophic myofibers (data not shown). Quantification of the cross-sectional area (CSA) of Atg7^−/−^ revealed that, although muscle atrophy was present in both oxidative and glycolytic fibers, it was more pronounced in the latter ([Figures 2](#fig2){ref-type="fig"}D and 2E).

The deterioration of *Atg7*^*−/−*^ muscles was also confirmed by the increase of center-nucleated fibers ([Figure 2](#fig2){ref-type="fig"}H). Correspondingly, *Atg7*^*−/−*^ muscles were weaker than controls both in adult and elderly mice ([Figures 2](#fig2){ref-type="fig"}F and 2G). Given that the features of atrophic fibers resemble denervated fibers, and a decline in innervation and loss of motor units are known to be important endogenous causes of sarcopenia, we tested whether denervation plays a role in the phenotype of *Atg7*^*−/−*^ mice. We first examined the expression pattern of the neural cell adhesion molecule (NCAM), a molecule that is enriched in the postsynaptic membrane of the NMJ but largely absent in adult myofibers. However, NCAM is re-expressed along the entire muscle fiber after the loss of innervation. Immunohistochemistry revealed that, during aging, there is a progressive increase of NCAM-positive fibers in controls. Importantly, *Atg7*^*−/−*^ muscles showed 5- to 7-fold more NCAM-positive fibers when compared to age-matched controls both in adult and elderly mice ([Figures 2](#fig2){ref-type="fig"}I--2K and [S1](#app2){ref-type="sec"}B). The expression of two other markers of denervation, MuSK (MUSK) and the acetylcholine receptor (AChR) γ-subunit (CHRNG) were significantly more upregulated in *Atg7*^*−/−*^ muscles ([Figure 2](#fig2){ref-type="fig"}L). To confirm these findings, we used a recently described in vivo imaging approach where two distinct AChR pools are differently color labeled ([@bib38; @bib39]) to monitor NMJ morphology and stability.

Automated image analysis revealed that, in contrast to control muscles, NMJs of adult *Atg7* knockout mice showed fragmented morphology ([Figures 3](#fig3){ref-type="fig"}A and 3B) and instability ([Figures 3](#fig3){ref-type="fig"}A and 3B). Whereas in controls, the changes in morphology and instability progressively increased with age, this was not the case in *Atg7* knockout mice ([Figure 3](#fig3){ref-type="fig"}B). NMJs of both adult and aged *Atg7*-deficient animals showed significantly more fragmentation and AChR turnover than 26-month-old (aged) control animals ([Figure 3](#fig3){ref-type="fig"}B, right panel).

Exocytic and endocytic processes mediate delivery of newly formed AChR and retrieval of old AChR, respectively. We monitored the localization and the number of the vesicles containing AChR. Inhibition of autophagy led to accumulation of vesicles close to the endplates that contain bungarotoxin (BGT) ([Figures 3](#fig3){ref-type="fig"}C and 3D), further corroborating an impairment of AChR turnover and of endosome trafficking. To determine whether alteration in endosome trafficking might also affect MuSK, a kinase that affects a plethora of signaling pathways that are important for NMJ stability, we monitored MuSK localization. Immunohistochemistry revealed that most MuSK colocalized with AChR at the plasma membrane in control fibers ([Figure 3](#fig3){ref-type="fig"}E). Importantly, *Atg7*^−/−^ caused a significant loss of MuSK on the plasma membrane and a concomitant enrichment of internalized MuSK ([Figure 3](#fig3){ref-type="fig"}E). These findings confirm an alteration of AChR and MuSK recycling and localization in *Atg7*^−/−^ mice. To determine whether the changes of NMJ are secondary to p62 (p62/SQSTM) accumulation into aggregates that clear signaling factors such as NRF2 or secondary to inhibition of the conjugation system, we knocked down p62 in *Atg7*^−/−^. For in vivo transfection experiments, we used bicistronic vectors that simultaneously encode small hairpin RNAs (shRNAs) and GFP. In this way, detection of GFP fluorescence allowed us to monitor the efficiency of transfection and the changes that occurred to p62-positive aggregates. After 14 days of transfection, *Atg7*^*−/−*^ tibialis anterior (TA) muscle was cleared by p62-positive inclusions ([Figure S2](#app2){ref-type="sec"}A). However, despite the absence of p62-positive aggregates, the percentage of denervated NCAM-positive fibers was not improved ([Figure S2](#app2){ref-type="sec"}B).

To understand the role of autophagy in age-related NMJ alterations, we used the inducible muscle-specific *Atg7* knockout mice that we have recently generated ([@bib30]). The *Atg7* gene was acutely deleted in 22-month-old mice, and mice were sacrificed 3 months later. Western blots for p62 and LC3 revealed that autophagy was successfully blocked in aged mice ([Figure 4](#fig4){ref-type="fig"}A). The inhibition of autophagy in old mice led to an exacerbation of muscle mass degeneration as revealed by the increase of centronucleated fibers and the decrease of CSA ([Figures 4](#fig4){ref-type="fig"}B and 4C). Fiber size distribution analysis revealed that acute *Atg7* deletion led to an enrichment of small fibers when compared to controls ([Figure S3](#app2){ref-type="sec"}), suggesting that denervation occurred in a discrete number of fibers. We then monitored NMJ to determine whether autophagy inhibition in old mice was sufficient to destabilize muscle-nerve interaction. *Atg7* deletion led to a significant increase of denervated NCAM-positive fibers ([Figure 4](#fig4){ref-type="fig"}D). Denervation is also supported by the finding that the *MuSK* transcript is significantly induced in *Atg7*^−/−^ ([Figure 4](#fig4){ref-type="fig"}E). Acute inhibition of autophagy in aged mice caused a significant loss of MuSK on the myofiber plasma membrane and a concomitant enrichment of internalized MuSK protein ([Figure 4](#fig4){ref-type="fig"}F).

Rescue of Atg7 Expression in Aged Mice Improves Neuromuscular Synaptic Function {#sec2.3}
-------------------------------------------------------------------------------

To determine the involvement of autophagy in NMJ maintenance during aging, we overexpressed ATG7 protein in 26-month-old *Atg7*^*f/f*^ mice to restore normal autophagy flux in aged mice. ATG7 expression was sufficient to increase LC3-positive vesicles in sarcopenic muscles ([Figure 5](#fig5){ref-type="fig"}A). When we monitored the effect of ATG7 expression on NMJ of aged mice, we found a significant improvement in morphology; NMJ was significantly less fragmented than age-matched controls ([Figures 5](#fig5){ref-type="fig"}B and 5C). Correspondingly, restoring autophagy in aged mice led to a decrease of vesicles close to the endplates that contain BGT, further corroborating a reactivation of AChR turnover and of endosome trafficking ([Figure 5](#fig5){ref-type="fig"}D). This was confirmed by the fact that MuSK localization was improved by the expression of ATG7 ([Figure 5](#fig5){ref-type="fig"}E). Rescuing ATG7 protein and autophagy led to a reduction of denervated NCAM-positive fibers that returned to the values of adult mice ([Figure 5](#fig5){ref-type="fig"}F). Finally, improvement of autophagy flux and NMJ morphology resulted in an enhancement in muscle mass ([Figure 5](#fig5){ref-type="fig"}G).

Autophagy Inhibition Enhances Mitochondrial Dysfunction and Oxidative Stress that Induces NMJ Instability {#sec2.4}
---------------------------------------------------------------------------------------------------------

One potential explanation of age-related loss of muscle mass and innervation is due to accumulation of dysfunctional mitochondria that generate an enhancement of reactive oxygen species (ROS) production and oxidative stress. Over the past years, several researchers have reported that oxidative stress might be involved in etiology of weakness, NMJ degeneration, and sarcopenia ([@bib19; @bib20]). In fact, inhibition of autophagy induced an accumulation of mitochondria as revealed by succinate dehydrogenase (SDH) staining ([Figure 6](#fig6){ref-type="fig"}A). Electron microscopy analyses revealed the presence of giant mitochondria containing abnormal cristae ([Figure 6](#fig6){ref-type="fig"}B). The abnormal mitochondria are also dysfunctional. *Atg7*^*−/−*^ flexor digitorum brevis (FDB) myofibers showed a significant increase of mitochondria that depolarized when the F~1~F~0~-ATPase was blocked by oligomycin ([@bib13]; [Figure 6](#fig6){ref-type="fig"}C). Similarly, FDB myofibers isolated from aged *Atg7*^*f/f*^ showed a significant increase in depolarized mitochondria, which was corrected by restoring ATG7 expression ([Figure S4](#app2){ref-type="sec"}A).

The alteration of mitochondrial morphology and function is associated with increased oxidative stress as revealed by protein carbonylation ([Figure 6](#fig6){ref-type="fig"}D). *Atg7*^*−/−*^ muscles showed a 2-fold increase of carbonylated proteins when compared to age-matched controls. We performed a proteomic approach on carbonylated proteins and found that mitochondrial and sarcomeric proteins are more oxidized in *Atg7*^*−/−*^ than controls ([Table S1](#app2){ref-type="sec"}; [Figure S4](#app2){ref-type="sec"}B). Because oxidative stress is believed to affect force generation, its enhancement might contribute to age-dependent weakness. Morphological and functional analyses on isolated single-skinned fibers confirmed that *Atg7*^*−/−*^ myofibers are more atrophic and generate less force ([Figures 6](#fig6){ref-type="fig"}E and [S4](#app2){ref-type="sec"}C). When the absolute force was normalized for myofiber size, the resulting specific force was still significantly lower ([Figure 6](#fig6){ref-type="fig"}F). Thus, not only the muscles became smaller, but there was a general impairment in force transmission, which led to profound weakness. The reduction of specific force may be caused by posttranslational modifications of contractile proteins induced by ROS. We then purified actin and myosin from *Atg7*^*−/−*^ muscles and confirmed that both proteins were more oxidized in *Atg7*^*−/−*^ mice ([Figure 6](#fig6){ref-type="fig"}G; [Table S1](#app2){ref-type="sec"}). Acto-myosin function was investigated using an in vitro motility assay approach ([@bib6]). Actin sliding velocity on both myosin and heavy meromyosin fraction (HMM) of *Atg7*^*−/−*^ was slower compared to controls ([Figure 6](#fig6){ref-type="fig"}H), confirming that an alteration of the functional properties of contractile proteins occurs when autophagy is reduced.

To test the role of oxidative stress in sarcopenia, we treated animals with Trolox, a potent antioxidant, for 4 weeks. The treatment successfully reduced the amount of total carbonylation on muscle protein extracts ([Figures 7](#fig7){ref-type="fig"}A and [S4](#app2){ref-type="sec"}B; [Table S1](#app2){ref-type="sec"}). Protein carbonylation of Trolox-treated *Atg7*^−/−^ no longer differed from age-matched controls. The proteomic approach confirmed that Trolox abolished the oxidation of mitochondrial and sarcomeric proteins ([Table S1](#app2){ref-type="sec"}; [Figure S4](#app2){ref-type="sec"}B). Importantly, antioxidant treatment blocked the oligomycin-dependent mitochondrial depolarization of *Atg7*^*−/−*^ mice ([Figure 7](#fig7){ref-type="fig"}B). We then addressed whether atrophy, weakness, and NMJ degeneration are affected by blunting oxidative stress. The treatment did not rescue myofiber size ([Figures 7](#fig7){ref-type="fig"}C and [S5](#app2){ref-type="sec"}) but reduced the drop of specific force in isolated *Atg7*-deficient myofibers ([Figure 7](#fig7){ref-type="fig"}D). Trolox completely prevented carbonylation of purified myosin and actin ([Figures 7](#fig7){ref-type="fig"}E and [S4](#app2){ref-type="sec"}B) and restored a normal acto-myosin function ([Figure 7](#fig7){ref-type="fig"}F). Looking at NMJ, we found that inhibition of ROS in adult *Atg7*^*−/−*^ mice partially reduced NMJ instability whereas it did not give protection from NMJ fragmentation ([Figure 7](#fig7){ref-type="fig"}G). In conclusion, these findings strongly suggest that ROS production directly affects acto-myosin interaction and force generation but shows a limited involvement in the changes occurring at NMJ and no effect on atrophy.

Discussion {#sec3}
==========

The present study provides several important insights concerning the role of autophagy in NMJ preservation during aging. The most striking conclusion is that autophagy controls two important destabilizing factors that are (1) the removal of dysfunctional mitochondria that produce ROS and (2) the endosome recycling of AChR that affects MuSK localization and muscle-nerve interaction. The consequence of aging is the deterioration of tissue function mainly due to accumulation of damaged DNA, proteins, and organelles. Autophagy is a critical system to maintain the cell clear from dysfunctional organelles and mis- or unfolded proteins that are prone to aggregate and to preserve DNA stability ([@bib42]). Due to these actions and that autophagy declines with aging, there is consensus in considering autophagy as an antiaging system. Genetic evidence in flies and worms sustain this concept, but these data are still lacking in mammals. In fact, autophagy knockout mice die as newborns due to a general energy failure ([@bib24]), and most of the tissue-specific knockouts ([@bib16; @bib22; @bib34]) show severe organ dysfunction that precludes aging studies. Instead, our findings support the notion that autophagy failure contributes to aging.

Aging is a multisystemic disorder that affects multiple organs, leading to alterations of metabolism and tissue function. The postmitotic tissues such as brain, heart, and skeletal muscle are the most susceptible to age-related disease, and their dysfunction contributes importantly to precocious aging. The important role of muscle in healthy aging has been sustained by recent studies in *Drosophila*. Activation of autophagy by overexpression of FOXO transcription factor in the muscles of flies increases longevity ([@bib9]). The extension of lifespan is due to reduction of food intake and insulin release from neurosecretory cells, confirming that maintenance of a normal autophagy level in skeletal muscle, but not in adipose tissue, positively affects whole-body metabolism ([@bib9]). However, the role of autophagy in age-related muscle loss in mammals is still unclear, being either beneficial or detrimental ([@bib12; @bib47; @bib48]). Our findings support the notion that autophagy is critical to prevent age-related denervation and weakness. Indeed, autophagy inhibition is sufficient to trigger a cascade of events that resemble those happening in elderly people.

Because mitochondria are the main producers of ROS, dysfunctional mitochondria are thought to play a key role in muscle function decline. In old age, a significant portion of mitochondria are abnormally enlarged, more rounded in shape, and display vacuolization in the matrix and shorter cristae ([@bib37]). Moreover, an increasing portion of them are also depolarized or nonfunctional. These features are present in autophagy-deficient muscles of adult animals, suggesting that defects in mitochondrial turnover are involved in age-dependent mitochondrial abnormalities. It is established that ROS production is increased in aged muscle in both the subsarcolemmal and intermyofibrillar pools of mitochondria ([@bib7]). This increase in ROS has been reported to induce oxidation of complex V, leading to decreased ATP production ([@bib37]). Accordingly, adult *Atg7*^*−/−*^ muscles showed a significant increase of carbonylated ATP synthase ([Table S1](#app2){ref-type="sec"}). Consistent with the ROS-mediated inhibition of ATP synthase, the energy-stress sensor of the cell, AMPK, is activated in *Atg7*-null muscles (not shown; [@bib30]). Our data show that mitochondrial dysfunction can be reversed by blocking ROS production. This finding is consistent with a recent report that showed improvement of age-related deficit, including mitochondrial function, by expressing a mitochondrial-targeted human catalase ([@bib25]).

Excessive ROS production does not only damage mitochondria but also cellular proteins. In muscle, oxidation of contractile proteins has been described, but the functional meaning of this condition is unclear. Our data establish that oxidative stress affects acto-myosin function and force generation. We showed by proteomic analyses that contractile proteins are carbonylated and that Trolox treatment reverts both protein oxidation and the myosin capacity of moving actin filaments, ultimately improving muscle force. It is well established that changes in muscle mass and strength tend to be dissociated in elderly persons, the decline of muscle strength being three times faster than the decrease of muscle mass ([@bib37]). This suggests that alteration in the quality of contractile proteins plays a critical role during age-related decrease of muscle force. Accordingly, *Atg7*^*−/−*^ myofibers show a significant decrease of force compared to age-matched controls, and this decline is corrected by Trolox. However, whereas the antioxidant improves acto-myosin function, it does not protect from muscle atrophy, although we cannot exclude that extending Trolox treatment for longer periods may successfully inhibit the signaling pathways controlling muscle atrophy. Previous studies reported that mitochondrial ROS production may contribute to NMJ instability ([@bib10; @bib19; @bib20]). Overexpression of uncoupling protein (UCP1), specifically in skeletal muscle, is sufficient to dismantle NMJ and to induce distal motor neuron degeneration ([@bib11]). Our data suggest that ROS partially contribute to NMJ instability. In fact, whereas Trolox treatment slightly reduced the turnover of old and new AChR, it did not prevent NMJ fragmentation.

In conclusion, our data strongly support the concept that autophagy in a postmitotic tissue is required for the correct interplay between muscle and nerve and for the quality control of mitochondria. Our findings also sustain the concept that the beneficial effects of caloric restriction and exercise on aging are a consequence of autophagy reactivation.

Experimental Procedures {#sec4}
=======================

Animals, Human Biopsies, In Vivo Transfection, and RNAi Experiments {#sec4.1}
-------------------------------------------------------------------

Animals were handled by specialized personnel under the control of inspectors of the Veterinary Service of the Local Sanitary Service (ASL 16---Padova), the local officers of the Ministry of Health. All procedures are specified in the projects approved by the Italian Ministero della Salute, Ufficio VI (authorization numbers C65). Subjects were male volunteers who received detailed information about the study and gave informed consent. Approval from the ethics committees of the City of Vienna and the Comenius University in Bratislava for medical ethics was obtained at the outset of the study. Muscle-specific Atg7-null (Atg7^−/−^) and tamoxifen-inducible muscle-specific Atg7^−/−^ mice have been previously described ([@bib30]). Tamoxifen-induced Cre LoxP recombination was activated by oral administration of tamoxifen-containing chow (Tam400/Cre ER Harlan). In vivo transfection and RNAi experiments were performed as previously described ([@bib43]). Sequences and plasmids are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. For in vitro validation of shRNA constructs, C2C12 cells were maintained in Dulbecco's modified Eagle's medium (DMEM)/10% fetal bovine serum and transfected with shRNA constructs using Lipofectamine 2000 (Life Technologies). Cells were lysed and processed for gene expression analyses or western blot.

Measurements of Muscle Force In Vivo {#sec4.2}
------------------------------------

Muscle force was measured in living animals as previously described ([@bib2]).

Single-Fiber Dissection, Solutions, and Experimental Setup {#sec4.3}
----------------------------------------------------------

The method used for single-muscle-fiber dissection, the solutions, and the experimental setup have been previously described ([@bib3]).

Single-Fiber Analysis {#sec4.4}
---------------------

Single-fiber analysis was performed as previously described ([@bib3]). The experiments were performed at a temperature of 12°C. Sarcomere length was determined and set at 2.5 μm. The CSA of the fibers was determined without correction for swelling. Absolute (Po) and specific forces (Po/CSA) of the fibers were determined. At the end of the mechanical experiment, fibers were put in 20 μl of Laemmli buffer and stored at −20°C for subsequent electrophoretic analysis of myosin heavy chain (MHC) isoform content.

Contractile Proteins for In Vitro Motility Assay {#sec4.5}
------------------------------------------------

### Myosin Extraction from Bulk Muscles {#sec4.5.1}

Myosin isoform 2B was extracted from bulk gastrocnemius muscles of mice according to a procedure previously described in detail ([@bib5]) and used to prepare the HMM.

### HMM Preparation {#sec4.5.2}

HMM was obtained by a proteolytic digestion with α-chimotrypsin of myosin according to a modification of the method of [@bib29] previously described in detail ([@bib5]).

### Actin Preparation {#sec4.5.3}

G-actin was extracted as described by [@bib35] from acetone powder prepared from the residues of mice muscles after myosin extraction. After polymerization, F-actin was labeled by incubation for several hours with rhodamine-phalloidine (Molecular Probes R415) as described by [@bib23].

IVMA {#sec4.6}
----

Myosin (or HMM) was diluted to 0.1 mg/ml in a high (or low) ionic strength buffer and infused in a flow cell treated with nitrocellulose and prepared according to [@bib1]. The in vitro motility assay (IVMA) analysis was performed according to [@bib5] and [@bib4] at 25°C. The composition of the experimental buffer was 3-(N-morpholino)propanesulfonic acid 25 mM (pH = 7.4 at 25°C), KCl 25 mM, MgCl~2~ 4 mM, EGTA 1 mM, dithiothreitol (DTT) 1 mM, glucose oxidase 200 μg/ml, catalase 36 μg/ml, glucose 5 mg/ml, and ATP 2 mM. Average velocities of actin filaments were determined. For each myosin and HMM sample, the velocities of at least 50 filaments were measured and their distribution characterized according to parametric statistics.

Gene-Expression Analyses {#sec4.7}
------------------------

Total RNA was prepared from TA muscles using Trizol Reagent (Life Technologies). Complementary DNA generated with Life Technologies SuperScript III Reverse Transcriptase was analyzed by quantitative real-time PCR using Power SYBR Green Applied Biosystem. All data were normalized to glyceraldehyde 3-phosphate dehydrogenase. The oligonucleotide primers used are shown in [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Immunoblotting {#sec4.8}
--------------

Cryosections of frozen gastrocnemius muscles were lysed in a buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl, 10 mM MgCl2, 0.5 mM DTT, 1 mM EDTA, 10% glycerol, 2% SDS, 1% Triton X-100, Roche Complete Protease Inhibitor Cocktail, and Sigma Protease Inhibitor Cocktail. The samples were immunoblotted as previously described ([@bib43]) and visualized with SuperSignal West Pico Chemiluminescent substrate (Pierce). A list of antibodies is shown in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Protein Carbonyls Detection and Antioxidant Treatment {#sec4.9}
-----------------------------------------------------

Carbonylation of muscle proteins was detected by using the OxyBlot Protein Oxidation Detection Kit from Millipore ([@bib30]). Mice were intraperitoneally injected with Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) 30 mg/kg daily for 4 weeks. For a detailed description of the detection of oxidized proteins, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

2D OxyBlot Data Acquisition and Analysis {#sec4.10}
----------------------------------------

Spot detection and quantification was carried out using the Image Master 2D Platinum 7 software (GE Healthcare). For a detailed description of the procedure, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

In-Gel Digestion, Mass Spectrometry Protein Identification, and Database Searches {#sec4.11}
---------------------------------------------------------------------------------

For a detailed description of the procedure, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Histology, Fluorescence Microscopy, and Electron Microscopy {#sec4.12}
-----------------------------------------------------------

Cryosections of TA were stained for hematoxylin and eosin (H&E) and SDH. Immunofluorescence staining was performed on cryostatic sections as previously described ([@bib30]) and then monitored with a fluorescence microscope or confocal microscopy. Antibodies are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. Fiber cross-sectional area was performed on TA or gastrocnemius (GCN) as described ([@bib27]) and measured using ImageJ software. For electron microscopy, we used conventional fixation-embedding procedures based on glutaraldehyde-osmium fixation and Epon embedding.

Cell Culture and Transient Transfections {#sec4.13}
----------------------------------------

C2C12 myogenic cell lines were cultured in DMEM (GIBCO-Life Technologies) supplemented with 10% fetal bovine serum. Myoblasts were transfected using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions.

Single-Fiber Mitochondrial Membrane Potential Analyses {#sec4.14}
------------------------------------------------------

Mitochondrial membrane potential was measured in isolated transfected fibers from FDB muscles. Mitochondrial membrane potential was measured by epifluorescence microscopy based on the accumulation of tetramethylrhodamine, methyl ester (TMRM) fluorescence as previously described ([@bib40]).

MHC Identification {#sec4.15}
------------------

The MHC isoform composition of gastrocnemius muscles of mice was assessed by 8% SDS polyacrylammide gel electrophoresis as described by [@bib36].

In Vivo Microscopy and Analysis of AChR Turnover and NMJ Fragmentation {#sec4.16}
----------------------------------------------------------------------

In vivo microscopy of mice was performed under anesthesia using Zoletil and xylazine on a Leica SP2 confocal microscope equipped with a 63× 1.2 numerical aperture water immersion objective, essentially as described previously ([@bib38; @bib39]). Automated analysis of AChR turnover and NMJ fragmentation used algorithms described earlier ([@bib39]).

Statistical Analysis and General Experimental Design {#sec4.17}
----------------------------------------------------

The sample size was calculated using size power analysis methods for a priori determination, based on the SD and effect size previously obtained using the experimental methods employed in the study. For animal studies, we estimated sample size from the expected number of knockout mice and littermate controls, which was based on Mendelian ratios. We calculated the minimal sample size for each group by at least four organisms. Considering a likely drop-off effect of 10%, we set the sample size of each group at five mice. To reduce the SD, we minimized physiological variation by using homogenous animals with the same sex and age. The exclusion criteria for animals were pre-established. In case of death, cannibalism, or sickness, the animal was excluded from analysis. Tissue samples were excluded in cases such as cryo-artifacts, histological artifacts, or failed RNA extraction. We included animals from different breeding cages by random allocation to the different experimental groups. Animal experiments were not blinded; however, when applicable, the experimenters were blinded to the nature of samples by using number codes until final data analysis was performed. Statistical tests were used as described in the figure legends and were applied upon verification of the test assumptions (e.g., normality). Generally, data were analyzed by Student's t test. For all graphs, data are represented as means ± SEM.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S5, and Table S1Document S2. Article plus Supplemental Information
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![Autophagy Is Impaired during Aging\
(A) Representative immunoblotting for the critical E1-like enzyme, ATG7, LC3II, and LC3I on muscle extracts from gastrocnemius of 10- and 26-month-old mice. The graphs show the quantification of ATG7 protein and the LC3II/LC3I ratio. Values are mean ± SEM; n = 4 of each condition; ^∗^p \< 0.05.\
(B) Aging reduces whereas exercise maintains expression of ATG7 and LC3 lipidation in humans. The graphs show the quantification of ATG7 protein and LC3II/LC3I ratio revealed by immunoblotting on muscle biopsies. Values are mean ± SEM; n = 6 young; n = 10 elderly, sedentary men; and n = 4 senior sportsmen; ^∗∗∗^p \< 0.0001.](gr1){#fig1}

![Morphological and Functional Changes in Muscles of Atg7^−/−^ during Aging\
(A) Kaplan-Meier curve of *Atg7*^*f/f*^ and *Atg7*^*−/−*^ mice. *Atg7*^*−/−*^ mice die earlier than their *Atg7*^*f/f*^ counterparts. Comparison of *Atg7*^*f/f*^ and *Atg7*^*−/−*^ survival curves was performed by both Mantel-Cox and Gehan-Breslow-Wilcoxon tests. *Atg7*^*−/−*^ mice show a significant reduction in the lifespan compared to controls (^∗^p \< 0.05).\
(B) Morphological analyses of aged *Atg7*^*f/f*^ and *Atg7*^*−/−*^ tibialis anterior (TA) muscles. H&E staining shows that *Atg7*^*−/−*^ muscles are atrophic with interstitial inflammation and center-nucleated fibers.\
(C) Higher magnification of atrophic fibers of aged *Atg7*^*−/−*^ mice showing angular, flat fibers and extremely small fibers (arrows).\
(D) Quantification of the cross-sectional area (CSA) of glycolitic myofibers in TA muscles of adult and aged *Atg7*^*f/f*^ and *Atg7*^*−/−*^ mice. Values are mean ± SEM. At least four muscles of each group were analyzed; ^∗∗^p \< 0.01; ^∗^p \< 0.05.\
(E) Quantification of CSA of oxidative myofibers of TA. Values are mean ± SEM; n \> 4 for each group; ^∗^p \< 0.05.\
(F and G) Force measurements performed in vivo. (F) *Atg7*^*−/−*^ mice show a profound decrease in maximal force generation in adult animals. Values are mean ± SEM (n = 5); ^∗∗^p \< 0.01. (G) Aging reduces force production in both *Atg7*^*f/f*^ and *Atg7*^*−/−*^ mice, therefore aggravating the already profound weakness of *Atg7*^*−/−*^ mice. Values are mean ± SEM; n = 4; ^∗^p \< 0.05.\
(H) Quantification of center-nucleated myofibers in TA (n \> 4 for each group; ^∗∗^p \< 0.01). Values are mean ± SEM.\
(I) Representative images of immunostaining for NCAM expression in aged mice. Localization of NCAM along the entire fibers indicates the loss of muscle-nerve interaction.\
(J) Immunoblotting for NCAM protein on muscle extracts from adult and aged gastrocnemius muscles. *Atg7*^*−/−*^ muscles express higher levels of NCAM than age-matched *Atg7*^*f/f*^.\
(K) Quantification of NCAM-positive fibers. Values were normalized for the total number of myofibers in muscle section (at least four muscles of each group were analyzed; ^∗∗^p \< 0.01). *Atg7*^*−/−*^ mice are characterized by much-higher age-dependent increase in NCAM-positive fibers than age-matched *Atg7*^*f/f*^. Values are mean ± SEM.\
(L) Expression levels of acetylcholine receptor AChR γ-subunit (CHRNG) (left) and MuSK (right). MuSK and AChR are upregulated in adult and aged Atg7^−/−^ muscles (n \> 5; ^∗^p \< 0.05). Values are mean ± SEM.](gr2){#fig2}

![Neuromuscular Junctions of *Atg7*^*−/−*^ Myofibers Are Unstable and Fragmented\
(A and B) Representative images of *Atg7*^*f/f*^ and *Atg7*^*−/−*^ neuromuscular junctions (NMJ) obtained using confocal in vivo microscopy. Muscles were in vivo pulse labeled with bungarotoxins (BGTs) conjugated with different fluorophores. BGT-Alexa Fluor 647 (shown in green) was injected 10 days before microscopy, thus identifying stable AChR, whereas BGT-Alexa Fluor 555 (shown in red), injected 1 hr prior to microscopy, identifies newly incorporated AChR. Micrographs show representative maximum z projections of confocal in vivo images of NMJs from *Atg7*^*f/f*^ (A) and *Atg7*^*−/−*^ (B). The panel on the right shows the quantification of AChR turnover as a function of NMJ fragmentation of adult and aged *Atg7*^*f/f*^ versus *Atg7*^*−/−*^. Data are from at least four muscles of each group; ^∗∗^p \< 0.01; ^∗^p \< 0.05. A.U., arbitrary units. In the right panel of (B), values are mean ± SEM.\
(C and D) Muscles were labeled with BGT-Alexa Fluor 555 48 hr before microscopy. In vivo confocal imaging was used to determine the amount of structures containing endocytic AChR. Micrographs show representative maximum z projections of confocal in vivo images of NMJs from *Atg7*^*f/f*^ (C) and *Atg7*^*−/−*^ (D). The panel on the right shows the average number of vesicular BGT-Alexa Fluor 555-positive structures per optical section. Data from 13 and 27 NMJs for *Atg7*^*f/f*^ and *Atg7*^*−/−*^, respectively; ^∗∗^p \< 0.01. In the right panel of (D), values are mean ± SEM.\
(E) Immunohistochemistry of MuSK expression on aged *Atg7*^*f/f*^ and *Atg7*^*−/−*^ myofibers. Upper panel shows normal pattern of NMJs in *Atg7*^*f/f*^ mice, where MuSK (red) localizes to NMJ, revealed by BGT-Alexa Fluor 647 (green). Lower panel shows MuSK (red) that accumulates inside myofibers at the level of NMJ (green). Panel on the right shows that the amount of diffused MuSK staining normalized over the total number of MuSK-positive NMJs is higher in aged *Atg7*^*−/−*^ than *Atg7*^*f/f*^; ^∗∗^p \< 0.01. In the right panel, values are mean ± SEM.](gr3){#fig3}

![Acute Inhibition of Autophagy in Aged Mice Exacerbates Features of Sarcopenia and NMJ Degeneration\
(A) Immunoblotting for LC3 and p62 proteins on muscle extracts from 25-month-old tamoxifen-inducible *Atg7*^*−/−*^ female mice. Three months after the tamoxifen treatment, skeletal muscles were collected and analyzed.\
(B) Acute inhibition of autophagy in old mice induces muscle degeneration. Quantification of the CSA of myofibers in TA muscles of aged tamoxifen-inducible *Atg7*^*−/−*^ and *Atg7*^*f/f*^ mice. Values are mean ± SEM; at least five muscles of each group were analyzed.\
(C) Quantification of center-nucleated myofibers in TA of tamoxifen-inducible *Atg7*^*−/−*^ (n \> 5 for each group; ^∗^p \< 0.05). Values are mean ± SEM.\
(D) Acute inhibition of *Atg7* in aged female mice increases the number of denervated NCAM-positive fibers when compared to age-matched controls. Values were normalized for the total number of myofibers in muscle section (at least five muscles of each group were analyzed; ^∗^p \< 0.05). Values are mean ± SEM.\
(E) Expression levels of MuSK after acute inhibition of Atg7 in old mice. MuSK is upregulated in aged tamoxifen-inducible *Atg7*^*−/−*^ muscles (^∗^p \< 0.05; n \> 5). Values are mean ± SEM.\
(F) Acute inhibition of autophagy in aged mice led to an increased amount of diffused MuSK staining; at least four muscles of each group were analyzed; ^∗∗∗^p \< 0.001. Values are mean ± SEM.](gr4){#fig4}

![Rescue of Atg7 Expression in Aged Mice Improves Neuromuscular Synaptic Function\
(A) Rescue of *Atg7* expression restores autophagosome formation in 26-month-old mice. TA muscles were transfected with *Atg7* expression plasmid, and 14 days later, TA were collected and stained for LC3 (green), p62 (red), and nuclei (blue).\
(B) Confocal in vivo microscopy showing that rescue of ATG7 expression greatly reduces AChR fragmentation (data from at least four muscles per group; ^∗^p \< 0.05) of aged *Atg7*^*f/f*^ mice. Representative images are shown.\
(C) Quantification of the AChR turnover as a function of NMJ fragmentation of aged *Atg7*^*f/f*^. Restoring *Atg7* expression greatly improves NMJ fragmentation; n = 189 NMJs for *Atg7*^*f/f*^ -GFP and 158 *Atg7*^*f/f*^ GFP-ATG7; ^∗∗^p \< 0.01. Values are mean ± SEM.\
(D) Average number of vesicular BGT-Alexa Fluor 555-positive structures per optical section. Data from 189 NMJs for *Atg7*^*f/f*^ -GFP and 158 *Atg7*^*f/f*^ GFP-ATG7, respectively; ^∗^p \< 0.05. Values are mean ± SEM.\
(E) Rescue of Atg7 expression and autophagy in aged mice decreased the amount of diffused MuSK staining (at least three muscles of each group were analyzed; ^∗∗∗^p \< 0.001; ^∗∗^p \< 0.01; ^∗^p \< 0.05). Values are mean ± SEM.\
(F) Restoring *Atg7* expression in aged mice improves the number of denervated NCAM-positive fibers when compared to age-matched controls and adult mice (three muscles of each group were analyzed; ^∗^p \< 0.05). Values are mean ± SEM.\
(G) Quantification of the CSA of myofibers in TA muscles of adult and aged *Atg7*^*f/f*^ in presence or absence of *Atg7* expression. Values are mean ± SEM; at least three muscles of each group were analyzed; ^∗^p \< 0.05.](gr5){#fig5}

![Autophagy Inhibition Induces Oxidative Stress and Mitochondrial Dysfunction\
(A) SDH staining on serial sections of aged *Atg7*^*f/f*^ and *Atg7*^*−/−*^ muscles (TA) shows an accumulation of abnormal mitochondria in *Atg7*^*−/−*^ myofibers.\
(B) Electron microscopy images of extensor digitorum longus muscles from aged *Atg7*^*f/f*^ and *Atg7*^*−/−*^ mice show accumulation of abnormal mitochondria displaying alterations in size, cristae morphology, and matrix density.\
(C) Measurement of mitochondrial membrane potential. TMRM staining was monitored in at least 20 fibers per group (^∗∗^p \< 0.001). Values are mean ± SEM.\
(D) Overall protein carbonylation of aged *Atg7*^*f/f*^ and *Atg7*^*−/−*^ muscles, revealed by Oxyblot. A representative immunoblot for carbonylated proteins is depicted on the left, and densitometric quantification of the carbonylated proteins is in the graph on the right. Aged *Atg7*^*−/−*^ mice show higher ongoing protein carbonylation than *Atg7*^*f/f*^ (n = 5; ^∗^p \< 0.05). Values are mean ± SEM.\
(E and F) In vitro analysis of isolated skinned muscle fibers from gastrocnemius muscles of *Atg7*^*f/f*^ and *Atg7*^*−/−*^. (E) Single *Atg7*^*−/−*^ myofibers are more atrophic (E) and weaker (F) than *Atg7*^*f/f*^ counterparts (at least 20 fibers for each condition; ^∗^p \< 0.05). Values are mean ± SEM.\
(G) Carbonylation of the pooled actin (on the left) and myosin (on the right) proteins, extracted from *Atg7*^*f/f*^ and *Atg7*^*−/−*^ GCN and used for in vitro motility assay. *Atg7*^*−/−*^ show higher carbonylation than *Atg7*^*f/f*^.\
(H) In vitro motility assay reveals reduced actin sliding velocity (*Vf*) on myosin (left panel) and HMM (right panel) extracted from adult *Atg7*^*−/−*^ muscles in comparison with *Atg7*^*f/f*^. Reduced actin sliding velocity was statistically significant in *Atg7*^*−/−*^ (n = 4 of each condition; ^∗∗^p \< 0.01) on both myosin and HMM. Values are mean ± SEM.](gr6){#fig6}

![Inhibition of Oxidative Stress Restores the Ability of Mitochondria to Maintain Membrane Potential and the Functionality of Actin-Myosin Complex but Shows Limited Effect on NMJ\
(A) Trolox treatment reduces the level of overall protein carbonylation in *Atg7*^*−/−*^ muscles, thus abolishing the difference with *Atg7*^*f/f*^ (n = 4 mice per condition; ^∗^p \< 0.05). Values are mean ± SEM.\
(B) Trolox treatment restores the ability of *Atg7*^*−/−*^ mitochondria to maintain membrane potential (n \> 20 fibers per group; ^∗∗^p \< 0.001). Values are mean ± SEM.\
(C) Trolox treatment does not affect fiber size in both *Atg7*^*f/f*^ and *Atg7*^*−/−*^ muscles (n = 4 mice per condition; ^∗∗^p \< 0.01). Values are mean ± SEM.\
(D) In vitro isolated skinned fiber analysis: Trolox treatment rescues the specific muscle force of isolated *Atg7*^*−/−*^ myofibers; data re-expressed as mean ± SD; n = 4 mice per condition; ^∗^p \< 0.05.\
(E) Trolox treatment reduces the level of actin (left panel) and myosin (right panel) protein carbonylation in *Atg7*^*−/−*^ muscles, thus abolishing the difference with *Atg7*^*f/f*^; n = 4 samples. Values are mean ± SEM.\
(F) Trolox treatment rescues actin sliding velocity (*Vf*) in adult *Atg7*^*−/−*^ muscles in in vitro motility assay; n = 4 mice per condition; ^∗∗^p \< 0.01. Values are mean ± SEM.\
(G) Confocal in vivo microscopy showing that Trolox treatment slightly reduces AChR turnover (data from at least four muscles per group; ^∗^p \< 0.05) but does not have any effect on NMJ fragmentation of adult *Atg7*^*f/f*^ and *Atg7*^*−/−*^ mice. Values are mean ± SEM.](gr7){#fig7}
